Robert S. Landsman

Array ( [id] => 13095569 [patent_doc_number] => 10067121 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-04 [patent_title] => Dynamic monitoring of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) activity and pathways in living cells using real-time microelectronic cell sensing technology [patent_app_type] => utility [patent_app_number] => 14/541024 [patent_app_country] => US [patent_app_date] => 2014-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 123 [patent_no_of_words] => 74387 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 252 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14541024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10398194 [patent_doc_number] => 20150283203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'METHOD FOR TREATING PROSTATITIS UTILIZING PORE-FORMING PROTEIN PROAEROLYSIN' [patent_app_type] => utility [patent_app_number] => 14/537429 [patent_app_country] => US [patent_app_date] => 2014-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19221 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14537429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9901022 [patent_doc_number] => 20150056222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'ANTI-PRLR ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/530265 [patent_app_country] => US [patent_app_date] => 2014-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31910 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14530265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11799648 [patent_doc_number] => 09540440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-10 [patent_title] => 'Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 14/528180 [patent_app_country] => US [patent_app_date] => 2014-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 35324 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 218 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14528180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11678316 [patent_doc_number] => 09676833 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-13 [patent_title] => 'Ang-2-binding modular recognition domain complexes and pharmaceutical compositions thereof' [patent_app_type] => utility [patent_app_number] => 14/527656 [patent_app_country] => US [patent_app_date] => 2014-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 36 [patent_no_of_words] => 67886 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14527656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10226236 [patent_doc_number] => 20150111229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'Method for Searching for Inhibitor of Odor Cause By Furaneol' [patent_app_type] => utility [patent_app_number] => 14/519958 [patent_app_country] => US [patent_app_date] => 2014-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6011 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14519958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10219459 [patent_doc_number] => 20150104453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'FDF03 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/517124 [patent_app_country] => US [patent_app_date] => 2014-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10307 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14517124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11283760 [patent_doc_number] => 09499604 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-22 [patent_title] => 'Trail mutant membrane-penetrating peptide-alike and methods of preparation thereof' [patent_app_type] => utility [patent_app_number] => 14/764740 [patent_app_country] => US [patent_app_date] => 2014-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 11 [patent_no_of_words] => 11448 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14764740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11437372 [patent_doc_number] => 20170038393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-09 [patent_title] => 'DIAGNOSIS AND TREATMENT OF IRRITABLE BOWEL SYNDROME AND INFLAMMATORY BOWEL DISEASE' [patent_app_type] => utility [patent_app_number] => 15/021850 [patent_app_country] => US [patent_app_date] => 2014-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15055 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12283261 [patent_doc_number] => 09931401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-03 [patent_title] => Combination comprising anti-fibroblast growth factor receptor 2 (FGFR2) antibody and a tyrosine kinase inhibitor [patent_app_type] => utility [patent_app_number] => 15/027489 [patent_app_country] => US [patent_app_date] => 2014-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 86 [patent_figures_cnt] => 166 [patent_no_of_words] => 60036 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15027489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10208404 [patent_doc_number] => 20150093393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'ANTI-PROLACTIN RECEPTOR ANTIBODY FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 14/501986 [patent_app_country] => US [patent_app_date] => 2014-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7687 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14501986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11031542 [patent_doc_number] => 20160228498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'METHODS OF PREVENTING OR TREATING MUCOSITIS USING RLIP76' [patent_app_type] => utility [patent_app_number] => 15/021924 [patent_app_country] => US [patent_app_date] => 2014-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15510 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9917924 [patent_doc_number] => 20150073129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'Combination therapy of antibodies against human CSF-1R and antibodies agains human PD-L1' [patent_app_type] => utility [patent_app_number] => 14/485140 [patent_app_country] => US [patent_app_date] => 2014-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27715 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14485140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10974770 [patent_doc_number] => 20140377806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'ANTI-CXCR3 ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/480052 [patent_app_country] => US [patent_app_date] => 2014-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 94 [patent_figures_cnt] => 94 [patent_no_of_words] => 29531 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14480052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16141517 [patent_doc_number] => 10703821 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-07 [patent_title] => Method for stimulating or enhancing proliferation of cells by activating the mucin 1 (MUC1) receptor [patent_app_type] => utility [patent_app_number] => 14/480586 [patent_app_country] => US [patent_app_date] => 2014-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 21444 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14480586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9793283 [patent_doc_number] => 20150005227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'METHOD OF TREATING AN ISCHEMIA-REPERFUSION INJURY-RELATED DISORDER BY ADMINISTERING GPCR LIGANDS' [patent_app_type] => utility [patent_app_number] => 14/479330 [patent_app_country] => US [patent_app_date] => 2014-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 41877 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14479330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10975312 [patent_doc_number] => 20140378347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'DIAGNOSTIC TEST' [patent_app_type] => utility [patent_app_number] => 14/478221 [patent_app_country] => US [patent_app_date] => 2014-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13343 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14478221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13184613 [patent_doc_number] => 10107821 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-23 [patent_title] => Proliferation-inducing ligand (APRIL)-binding peptides [patent_app_type] => utility [patent_app_number] => 14/916962 [patent_app_country] => US [patent_app_date] => 2014-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 18824 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9909038 [patent_doc_number] => 20150064239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-05 [patent_title] => 'METHODS FOR IDENTIFYING MODULATORS OF IL-24 MEDIATED APOPTOSIS AND IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 14/476259 [patent_app_country] => US [patent_app_date] => 2014-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5221 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14476259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10208398 [patent_doc_number] => 20150093388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'Antibodies and Assays for Detection of Folate Receptor 1' [patent_app_type] => utility [patent_app_number] => 14/473828 [patent_app_country] => US [patent_app_date] => 2014-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 44624 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14473828 [rel_patent_id] =>[rel_patent_doc_number] =>)